|
THUMPD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.18710041796533E-10 |
| Normal-vs-Stage3 |
2.11479944667303E-10 |
| Normal-vs-Stage4 |
2.46669351611217E-12 |
| Stage1-vs-Stage2 |
2.040400E-01 |
| Stage1-vs-Stage3 |
5.359200E-01 |
| Stage1-vs-Stage4 |
2.159400E-01 |
| Stage2-vs-Stage3 |
1.512220E-01 |
| Stage2-vs-Stage4 |
9.287600E-01 |
| Stage3-vs-Stage4 |
1.056560E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.86269999999223E-05 |
| Normal-vs-Asian |
8.94160000486366E-08 |
| Caucasian-vs-AfricanAmerican |
2.803200E-01 |
| Caucasian-vs-Asian |
1.692620E-01 |
| AfricanAmerican-vs-Asian |
9.550600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22210036429738E-11 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.807620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
3.68483021873089E-13 |
| Normal-vs-Age(61-80Yrs) |
3.66069952129067E-10 |
| Normal-vs-Age(81-100Yrs) |
5.92309999999374E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.794400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.178200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.832000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.701200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.282200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.484000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.159700E-02 |
| Classical-VS-Follicular |
9.379800E-01 |
| Classical-VS-Other |
4.619200E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
1.572040E-01 |
| Tall-VS-Other |
2.582000E-01 |
| Tall-VS-Normal |
2.74935629818174E-12 |
| Follicular-VS-Other |
6.246800E-01 |
| Follicular-VS-Normal |
3.62800000042185E-08 |
| Other-VS-Normal |
2.118100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.99360577730113E-15 |
| Normal-vs-N1 |
4.2534999966648E-09 |
| N0-vs-N1 |
7.366400E-01 |
|
|
